Six years after an embarrassing episode came to light, Dr. Reddy’s Laboratories has agreed to pay a $5 million fine for knowingly distributing medicines in blister packs that were not child resistant as required by federal law.

In disclosing the settlement, the U.S. Department of Justice noted that packaging engineers at the company’s subsidiary in New Jersey prepared a report in 2011 detailing how child-resistant blister packs for several medicines did not meet federal standards. Despite being urged by its own employees to test the packaging, the company shipped the generic medicines anyway, according to court documents.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy